
-
CORPORATE - 16-10-2019
FSI SGR enters Kedrion share capital
The company continues with its growth and development strategy
read more -
CORPORATE - 04-10-2019
Kedrion submits to FDA for Manufacture of RhoGAM/MICRhoGAM in Melville, NY
read more -
CORPORATE - 30-01-2019
Kedrion Biopharma Announces Completion of Enrollment for CARES10
A Phase 3, Multi-Center Study to Assess a 10% Ig in Adults with Primary Immunodeficiency Disease
read more
For more information please contact: pressoffice@kedrion.com